Xiaosong Meng
Urology · Dallas, TXNPI 1003227802
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.1%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Profound Medical Corp. at 44.2% of the total. Reporting peaked in 2024 at $8,563 and has fallen 61.6% since, to $3,290 in 2025.
Across 112 payments — averaging $155.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Profound Medical Corp.$8K
- EDAP Technomed Inc$3K
- Angiodynamics, Inc.$1K
- AstraZeneca$775
- Dendreon Pharmaceuticals LLC$405
- Medtronic$378
- plus $4K from 27 others
Across 2 payments — averaging $750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Angiodynamics, Inc.$2K
What the payments were for
- Speaking & faculty fees$2061%
- Travel & lodging$7,14841%
- Food & beverage$9,74956%
- Entertainment$2802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Profound Medical Corp. | 16 | $7,681 |
| EDAP Technomed Inc | 21 | $3,215 |
| Angiodynamics, Inc. | 12 | $1,258 |
| AstraZeneca | 6 | $775 |
| Dendreon Pharmaceuticals LLC | 2 | $405 |
| Medtronic | 5 | $378 |
| Progenics Pharmaceuticals, Inc. | 3 | $307 |
| Teleflex LLC | 3 | $297 |
| Conmed Corporation | 3 | $239 |
| Janssen Scientific Affairs, LLC | 3 | $236 |
| Procept Biorobotics Corporation | 2 | $210 |
| Foundation Medicine, Inc. | 2 | $205 |
| Blue Earth Diagnostics | 2 | $203 |
| Bioprotect Medical, Inc. | 3 | $199 |
| Immunitybio, Inc. | 2 | $183 |
| Shockwave Medical, Inc | 1 | $139 |
| Penumbra, Inc. | 1 | $139 |
| KARL Storz Endoscopy-america | 2 | $134 |
| Clovis Oncology, Inc. | 1 | $133 |
| Bayer | 1 | $131 |
| Myovant Sciences Inc. | 1 | $122 |
| Urogen Pharma, Inc. | 2 | $106 |
| Amgen | 1 | $106 |
| Agiliti Surgical, Inc. | 1 | $95 |
| EMD Serono, Inc. | 1 | $95 |
| Photocure Inc | 1 | $92 |
| Pfizer | 3 | $64 |
| Astellas Pharma US Inc | 3 | $51 |
| Olympus America Inc. | 2 | $51 |
| Innovation Technologies Inc | 2 | $49 |
| Urovant Sciences Inc | 2 | $37 |
| AbbVie | 1 | $31 |
| Boston Scientific | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tulsa-Pro$7,093
- Nanoknife$794
- LYNPARZA$592
- PROVENGE$405
- PYLARIFY$287
- AquaBeam Robotic System$210
- FOUNDATIONONE LIQUID CDX$205
- INTERSTIM$162
- CONCERTOTM$153
- ANKTIVA$150
- AlphaVac$141
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$139
- Smart Coil$139
- Rubraca$133
- Xofigo$131
- ORGOVYX$122
- AIRSEAL$107
- XGEVA$106
- Axumin$103
- FOUNDATIONONE$100
How this compares
$17,382 in reported general payments places this provider in the 85th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Silodosin | 39 | $2,411 |
| Tamsulosin Hcl | 75 | $639 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 33 | $334 |
| Finasteride | 35 | $322 |
| Cephalexin | 16 | $42 |
| Dexamethasone | 17 | $26 |
| Ciprofloxacin Hcl | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other urology in Dallas
- Allen MoreyDallas$914K
- Vitaly MargulisDallas$555K
- Yair LotanDallas$371K
- Claus RoehrbornDallas$169K
- Samantha NealonDallas$89K
- Maia VandykeDallas$79K
- Gary LemackDallas$62K
- Brian LangfordDallas$57K
- Jonathan SeamanDallas$55K
- Andrew von EschenbachMontgomery$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.